1997
DOI: 10.1172/jci119142
|View full text |Cite
|
Sign up to set email alerts
|

Selectin ligands: will the real ones please stand up?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

8
231
0
5

Year Published

1998
1998
2008
2008

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 287 publications
(244 citation statements)
references
References 75 publications
8
231
0
5
Order By: Relevance
“…L-selectin is a major carbohydrate-presenting ligand for E-selectin on human neutrophils identified in vitro but the actual in vivo ligand may be an unique mucin modified with N-linked sugars that has been characterized in murine cells and called E-selectin ligand-1 (Willmroth and Beaudet, 1999). L-selectin binds to at least three glycoproteins: Gly-CAM-1, CD-34, and MAdCAM-1 which are expressed on the endothelial cell surface, the most probable being a fucosylated variant of CD34 (Tedder et al, 1995;Varki, 1997). P-selectin interacts with its leukocyte counterpart, P-selectin glycoprotein ligand-1 (PSGL-1) which is, like CD34, modified with O-linked sialic acid and fucose (McEver and Cummings, 1997).…”
Section: Molecular Mechanisms That Control Leukocyte Extravasationmentioning
confidence: 99%
“…L-selectin is a major carbohydrate-presenting ligand for E-selectin on human neutrophils identified in vitro but the actual in vivo ligand may be an unique mucin modified with N-linked sugars that has been characterized in murine cells and called E-selectin ligand-1 (Willmroth and Beaudet, 1999). L-selectin binds to at least three glycoproteins: Gly-CAM-1, CD-34, and MAdCAM-1 which are expressed on the endothelial cell surface, the most probable being a fucosylated variant of CD34 (Tedder et al, 1995;Varki, 1997). P-selectin interacts with its leukocyte counterpart, P-selectin glycoprotein ligand-1 (PSGL-1) which is, like CD34, modified with O-linked sialic acid and fucose (McEver and Cummings, 1997).…”
Section: Molecular Mechanisms That Control Leukocyte Extravasationmentioning
confidence: 99%
“…Fractionation of in vivo [3 H]-glucosamine labeled PSGL-1 glycopeptides on Concanavalin A-Sepharose (0.8 ml bed volume) was done essentially as described by Merkle and Cummings [22]. Bound glycopeptides were sequentially eluted with 10 mM amethylglucoside followed by 100 m M a-methylmannoside at 55 o C; fraction volume was 2 ml.…”
Section: Lectin Chromatographymentioning
confidence: 99%
“…The interaction(s) between the selectins and the target cells is mediated by oligosaccharide structures conjugated to specific ligand molecules expressed on the target cell surfaces. These ligand molecules may be recognized by one, two or all three of the selectins [1][2][3]. Although available data suggest that the interaction(s) between the selectins and their ligands in most cases is mediated by O-linked oligosaccharide structures, spe-cific binding of E-selectin to N-linked oligosaccharides has been reported [4][5][6].…”
Section: Introductionmentioning
confidence: 99%
“…11,12 Functionally, the binding of selectins to leukocytes requires sialylated and fucosylated carbohydrate structures; their prototypes are SAa2-3Galb1-4(Fuca1-3)GlcNAc and SAa2-3Galb1-3(Fuca1-4)GlcNAc, referred to as sLe x and sLe a , respectively. [13][14][15] Both sLe x and sLe a are involved in selectin-mediated adhesion of cancer cells to vascular endothelium, and these determinants are thought to be closely associated with hematogenous metastasis of cancers. [16][17][18][19] These determinants not only are markers for cancer but also are functionally implicated in the malignant behavior of cancer cells.…”
mentioning
confidence: 99%